Statins × all-cause mortality

SynthesisDiabetes & metabolic syndrome2022

Association of statin and/or renin-angiotensin-aldosterone system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European study.

Sophie Harris et al.PubMed ↗Full text ↗Publisher ↗

What moved togetherboth groups pooled, not the treatment’s effect

Correlation · may be no link

No clear link with deaths

+9%−22% to +52%

Bigger than 3 in 10 for all-cause mortality

As reported

OR 1.09, 95% CI 0.78–1.52 · the paper's word: All-cause mortality

One number in the abstract

the abstract, start to end

and prescription of RAASi therapy (OR 1.09, CI 0.78-1.52 (I CONCLUSIONS:

← favours treatmentfavours comparator →
could be chance
All-cause mortality
OR 1.090.78–1.52
StatinsAll-cause mortality
1 / 3

3 papers cite it

2022
2023
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35472685